ArticleOncotarget2017

Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation.

Stefania Napolitano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.